BPRRX Fees and Costs — Boston Partners Long/Short Research Fund, Investor Class
Data updated: 2026-07-28
The net expense ratio is 1.84%. There are no sales loads or redemption fees. In fiscal 2024 the fund paid $694K in broker commissions, 0.1163% of average net assets, and portfolio turnover was 65%.
BPRRX Fees and Expenses
Annual operating expenses and sales charges of BPRRX. Prospectus, as of July 3, 2026.
| Annual operating expenses | |
|---|---|
| Management fee | 1.25% |
| 12b-1 fee | 0.00% |
| Other expenses | 0.16% |
| Gross expense ratio | 1.84% |
| Fee waiver | — |
| Net expense ratio | 1.84% |
| Sales charges | |
|---|---|
| Max front load | — |
| Max deferred load | — |
| Redemption fee | — |
| Expense limitation in place (N-CEN) | Yes |
| Fees waived or reduced during the year | No |
| Waived fees subject to recoupment | Yes |
BPRRX Costs Over Time
On $10,000 invested in BPRRX, assuming 5% a year before costs, total costs come to $1,200 over 5 years, cutting the return by 2.05% a year. Illustration, not a forecast: it assumes today's net expense ratio throughout (a fee waiver may end).
| $10,000 invested | Sell after 1 year | Sell after 3 years | Sell after 5 years |
|---|---|---|---|
| Value before costs | $10,500 | $11,576 | $12,763 |
| Fund expenses (net expense ratio 1.84%) | $193 | $597 | $1,025 |
| Trading costs (broker commissions) | $12 | $38 | $65 |
| Lost growth on money paid in costs | $0 | $32 | $111 |
| Total costs | $205 | $666 | $1,200 |
| Value after costs | $10,295 | $10,910 | $11,562 |
| Impact on return, per year | 2.05% | 2.05% | 2.05% |
BPRRX Trading Costs
Brokerage costs reported on SEC Form N-CEN for the fiscal year ending August 31, 2024.
- Explicit cost rate (commissions ÷ average net assets): 0.1163%
- Total broker commissions: $694K
- Bought from dealers (principal trades, not a cost): $49.0M
- Portfolio turnover (prospectus): 65%
- Securities lending: none during the year
BPRRX Agency Brokers
Commissions paid.
| Broker | Amount | Share |
|---|---|---|
| MORGAN STANLEY & CO. LLC | $143K | 22.26% |
| RBC CAPITAL MARKETS LLC | $113K | 17.63% |
| J.P. MORGAN SECURITIES LLC | $100K | 15.69% |
| UBS ASSET MANAGEMENT (US) INC. | $98K | 15.35% |
| GOLDMAN SACHS & CO. LLC | $81K | 12.70% |
| JEFFERIES LLC | $47K | 7.32% |
| NATIONAL FINANCIAL SERVICES LLC | $34K | 5.34% |
| MERRILL LYNCH PIERCE FENNER & SMITH INCORPORATED | $10K | 1.52% |
| LIQUIDNET INC. | $7K | 1.10% |
| ACADEMY SECURITIES INC | $7K | 1.10% |
BPRRX Dealer Counterparties
Securities bought directly from dealers (principal trades).
| Broker | Amount | Share |
|---|---|---|
| MORGAN STANLEY & CO. LLC | $48.0M | 95.40% |
| INSTINET LLC | $1.7M | 3.32% |
| ROBERT W. BAIRD & CO. INCORPORATED | $632K | 1.26% |
| J.P. MORGAN SECURITIES LLC | $8K | 0.02% |
| GOLDMAN SACHS & CO. LLC | $3K | 0.01% |
| MERRILL LYNCH PIERCE FENNER & SMITH INCORPORATED | $2K | 0.00% |
| JEFFERIES LLC | $420 | 0.00% |
Boston Partners Long/Short Research Fund Share Classes
Net expense ratio and maximum front-end load of each share class, cheapest first.
| Ticker | Class | Net expense ratio | Front load |
|---|---|---|---|
| BPRRX | Investor Class | 1.84% | — |
| BPIRX | Institutional Class | 2.09% | — |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.